Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model

Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis

(2013) S. Hoshiko et al.   CANCER RESEARCH

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness

(2012) Takashi Baba et al.   JOURNAL OF PATHOLOGY

Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells

(2012) Kazuyo Kohama et al.   Human Cell

Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression

(2011) Newton J. Hurst et al.   BIOCHEMICAL JOURNAL

Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase

(2011) Takahiro Domoto et al.   CANCER SCIENCE

Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease

(2011) M. Kato et al.   JOURNAL OF BIOCHEMISTRY

The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment

(2010) Toni M. Antalis et al.   BIOCHEMICAL JOURNAL

ST14 Gene Variant and Decreased Matriptase Protein Expression Predict Poor Breast Cancer Survival

(2010) J. M. Kauppinen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A Novel Signaling Axis of Matriptase/PDGF-D/ -PDGFR in Human Prostate Cancer

(2010) C. V. Ustach et al.   CANCER RESEARCH

Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells

(2010) Tsuyoshi Fukushima et al.   CANCER SCIENCE

Local Protease Signaling Contributes to Neural Tube Closure in the Mouse Embryo

(2010) Eric Camerer et al.   DEVELOPMENTAL CELL

TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor

(2010) Tomio Hashimoto et al.   FEBS Journal

Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo

(2010) Hiroaki Kataoka et al.   FEBS Journal

The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer

(2010) Keiichiro Nakamura et al.   INTERNATIONAL JOURNAL OF CANCER

Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer

(2010) Andrea Pia Elste et al.   JOURNAL OF MOLECULAR HISTOLOGY

Expression of Hepatocyte Growth Factor Activator Inhibitor Type 1 in Human Hepatocellular Carcinoma and Postoperative Outcomes

(2010) Mayumi Funagayama et al.   WORLD JOURNAL OF SURGERY

Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA

(2009) Kate A. Owen et al.   BIOCHEMICAL JOURNAL

Hepatocyte Growth Factor Activator Inhibitor Type 1 Regulates Epithelial to Mesenchymal Transition through Membrane-Bound Serine Proteinases

(2009) H. Cheng et al.   CANCER RESEARCH

Role of Matriptase and Proteinase-Activated Receptor-2 in Nonmelanoma Skin Cancer

(2009) Georgeta Bocheva et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases

(2008) Shoichiro Mukai et al.   FEBS Journal

Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses

(2008) Wataru Komaki et al.   VIRCHOWS ARCHIV